Novo Nordisk A/S

Novo Nordisk A/Sverified

NOVC.DE

Price:

$91.4

Market Cap:

$1.38T

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also ...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2001-06-07

Stock Exchange

XETRA

Ticker

NOVC.DE

The Enterprise Value as of December 2025 (TTM) for Novo Nordisk A/S (NOVC.DE) is 1.46T

According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 1.46T. This represents a change of -44.82% compared to the average of 2.64T of the last 4 quarters.

Novo Nordisk A/S (NOVC.DE) Historical Enterprise Value (quarterly & annually)

How has NOVC.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Novo Nordisk A/S over the last ten years is 1.49T. The current 1.46T Enterprise Value has changed 9.67% with respect to the historical average. Over the past ten years (40 quarters), NOVC.DE's Enterprise Value was at its highest in in the June 2024 quarter at 4.48T. The Enterprise Value was at its lowest in in the March 2017 quarter at 581.59B.

Quarterly (TTM)
Annual

Average

1.49T

Median

1.00T

Minimum

625.92B

Maximum

3.14T

Novo Nordisk A/S (NOVC.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novo Nordisk A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.57%

Maximum Annual Enterprise Value = 3.14T

Minimum Annual Increase = -38.16%

Minimum Annual Enterprise Value = 625.92B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20242.87T-8.75%
20233.14T46.96%
20222.14T25.45%
20211.70T71.57%
2020993.33B9.52%
2019907.01B25.77%
2018721.16B-10.84%
2017808.80B29.22%
2016625.92B-38.16%
20151.01T51.35%

Novo Nordisk A/S (NOVC.DE) Average Enterprise Value

How has NOVC.DE Enterprise Value performed in the past?

The current Enterprise Value of Novo Nordisk A/S (NOVC.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.72T

5-year avg

2.17T

10-year avg

1.49T

Novo Nordisk A/S (NOVC.DE) Enterprise Value vs. Peers

How is NOVC.DE’s Enterprise Value compared to its peers?

Novo Nordisk A/S’s Enterprise Value is greater than Walgreens Boots Alliance, Inc. (38.64B), greater than Henry Schein, Inc. (12.70B), greater than Shop Apotheke Europe N.V. (1.20B), greater than Baxter International Inc. (17.73B), greater than Koninklijke Philips N.V. (28.32B), greater than Synlab AG (3.77B), greater than DENTSPLY SIRONA Inc. (4.35B), greater than PharmaSGP Holding SE (305.40M), greater than ViewRay, Inc. (-44998227.00), greater than CompuGroup Medical SE & Co. KGaA (1.88B),

Build a custom stock screener for Novo Nordisk A/S (NOVC.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novo Nordisk A/S (NOVC.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Novo Nordisk A/S's Enterprise Value?

What is the highest Enterprise Value for Novo Nordisk A/S (NOVC.DE)?

What is the 3-year average Enterprise Value for Novo Nordisk A/S (NOVC.DE)?

What is the 5-year average Enterprise Value for Novo Nordisk A/S (NOVC.DE)?

How does the current Enterprise Value for Novo Nordisk A/S (NOVC.DE) compare to its historical average?